Works Cited
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.
1. Arevalo-Rodriguez I, Smailagic N, Roqué-Figuls M, et al. Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI). Cochrane Database of Systematic Reviews. 2021;7(7):CD010783.
2. Bir SC, Khan MW, Javalkar V, Toledo EG, Kelley RE. Emerging concepts in vascular dementia: a review. Journal of Stroke and Cerebrovascular Diseases. 2021;30(8):105864.
3. Boeve BF, Boxer AL, Kumfor F, Pijnenburg Y, Rohrer JD. Advances and controversies in frontotemporal dementia: diagnosis, biomarkers, and therapeutic considerations. Lancet Neurology. 2022;21(3):258-272.
4. Brodaty H, Pond D, Kemp NM, Luscombe G, Harding L, Berman K, Huppert FA. The GPCOG: a new screening test for dementia designed for general practice. Journal of the American Geriatrics Society. 2002;50(3):530-534.
5. Burton JK, Fearon P, Noel-Storr AH, McShane R, Stott DJ, Quinn TJ. Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the detection of dementia within a secondary care setting. Cochrane Database of Systematic Reviews. 2021;7(7):CD010772.
6. Chapman S, Joyce JL, Barker MS, et al. Subjective cognitive decline is more accurate when metamemory is better. Frontiers in Aging Neuroscience. 2022;14:787552.
7. Chun CT, Seward K, Patterson A, Melton A, MacDonald-Wicks L. Evaluation of available cognitive tools used to measure mild cognitive decline: a scoping review. Nutrients. 2021;13(11):3974.
8. Ciccone I. Women Patients and Caregivers Report Greater Impact from Dementia with Lewy Bodies. Available at https://www.neurologylive.com/view/women-patients-caregivers-report-greater-impact-dementia-lewy-bodies.
9. Cui L, Zhang Z, Huang L, Li Q, Yi-Han G, Qi-Hao G. Dual-stage cognitive assessment: a two-stage screening for cognitive impairment in primary care. BMC Psychiatry. 2023;23:1-10.
10. Curiel Cid RE, Crocco EA, Kitaigorodsky M, et al. A novel computerized cognitive stress test to detect mild cognitive impairment. Journal of Prevention of Alzheimer's Disease. 2021;8(2):135-141.
11. Davis DH, Creavin ST, Yip JL, Noel-Storr AH, Brayne C, Cullum S. Montreal Cognitive Assessment for the detection of dementia. Cochrane Database of Systematic Reviews. 2021;7(7):CD010775.
12. Deb A, Thornton JD, Sambamoorth U, Innes K. Direct and indirect cost of managing Alzheimer’s disease and related dementias in the United States. Expert Review of Pharmacoeconomics Outcomes Research. 2017;17(2):189-202.
13. Dening KH. Dementia 1: types, risk factors, and recognising signs and symptoms: NT. Nursing Times. 2023;119:18-23.
14. Dujardin K, Duhem S, Guerouaou N, et al. Validation in French of the Montreal Cognitive Assessment 5-Minute, a brief cognitive screening test for phone administration. Revue Neurologique. 2021;177(8):972-979.
15. Fage BA, Chan CC, Gill SS, et al. Mini-Cog for the detection of dementia within a community setting. Cochrane Database of Systematic Reviews. 2021;7(7):CD010860.
16. Forns J, Danysh HE, McQuay LJ, et al. Clinical outcomes and treatment patterns of older adults with dementia-related psychosis by dementia type in the United States. BMC Geriatrics. 2022;22:1-10.
17. Guo QH, Zhou B, Zhao QH, Wang B, Hong Z. Memory and Executive Screening (MES): a brief cognitive test for detecting mild cognitive impairment. BMC Neurology. 2012;12:119.
18. Hall PA, Burhan AM, MacKillop JC, Duarte D. Next-generation cognitive assessment: combining functional brain imaging, system perturbations and novel equipment interfaces. Brain Research Bulletin. 2023;204:110797.
19. Hsu JH, Liu CC, Chen IW, et al. Efficacy of the visual cognitive assessment test for mild cognitive impairment/mild dementia diagnosis: a meta-analysis. Frontiers in Public Health. 2023;11:1293710.
20. Jia L, Du Y, Chu L, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet: Public Health. 2020;5(12):e661-e671.
21. Julayanont P, Nasreddine ZS. Montreal Cognitive Assessment (MoCA): concept and clinical review. In: Larner AJ (ed). Cognitive Screening Instruments. Springer; 2017.
22. Libon DJ, Delano-Wood L, Bondi MW. Mild cognitive impairment. In: Kreutzer JS, DeLuca J, Caplan B (eds). Encyclopedia of Clinical Neuropsychology. Springer; 2021.
23. Liu Y, Xie B, Li Q, et al. Visual Cognitive Assessment Test: utility of the brief cognitive battery for early screening of cognitive impairment in Chongqing, China. Brain and Behavior. 2024;14(2).
24. Lui L, Zhang Z, Huang L, Li Q, Yi-Han G, Qi-Hao G. Dual-stage cognitive assessment: a two-stage screening for cognitive impairment in primary care. BMC Psychiatry. 2023;23:1-10.
25. Nandi A, Counts N, Bröker J, et al. Cost of care for Alzheimer’s disease and related dementias in the United States: 2016 to 2060. NPJ Aging. 2024;10.
26. Petersen RC, Wiste HJ, Weigand SD, et al. NIA-AA Alzheimer’s Disease Framework: clinical characterization of stages. Annals of Neurology. 2021;89(6):1145-1156.
27. Prasad S, Katta MR, Abhishek S, et al. Recent advances in Lewy body dementia: a comprehensive review. Disease-a-Month. 2023;69(5):101441.
28. Quitoriano J, Hamm RM. In patients suspected of cognitive decline, what is the most accurate in-office screening instrument to determine if there is dementia needing further evaluation and management? Journal of the Oklahoma State Medical Association. 2017;110(8):454-457.
29. Sanders AE, School C, Kalish VB. Vascular Dementia. Available at https://www.ncbi.nlm.nih.gov/books/NBK430817.
30. Scheltens P, De Strooper B, Kivipelto M, et al. Alzheimer's disease. Lancet. 2021;397(10284):1577-1590.
31. Schmidt K. Clinical dementia rating scale. In: Maggino F (ed). Encyclopedia of Quality of Life and Well-Being Research. Springer; 2021.
32. Seitz DP, Chan CC, Newton HT, et al. Mini-Cog for the diagnosis of Alzheimer’s disease dementia and other dementias within a primary care setting. Cochrane Database of Systematic Reviews. 2018;2(2):CD011415.
33. Siddiqui M, Nyahoda T, Traber C, et al. Screening for cognitive impairment in primary care: rationale and tools. Missouri Medicine. 2023;120(6):431-439.
34. Sideman AB, Ma M, Hernandez de Jesus A. Primary care practitioner perspectives on the role of primary care in dementia diagnosis and care. JAMA Network Open. 2023;6(9):e2336030.
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.